Dalfampridine Hydrochloride is a potassium channel blocker indicated to improve walking in adult patients with multiple sclerosis by facilitating nerve impulse conduction in demyelinated axons. As a pharmaceutical… Read more
Dalfampridine Hydrochloride is a potassium channel blocker indicated to improve walking in adult patients with multiple sclerosis by facilitating nerve impulse conduction in demyelinated axons. As a pharmaceutical agent, it is essential that the drug undergoes rigorous analytical assessment to ensure consistency, efficacy, and safety. The related compounds in this category, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled reference standards, are critical tools in this process. Laboratories utilize these high-quality materials for impurity profiling, method validation, and routine quality control testing to accurately quantify the active pharmaceutical ingredient and monitor potential degradants. Stable isotope-labelled compounds, in particular, serve as precise internal standards for mass spectrometry-based assays, enabling reliable identification and quantitation of the drug and its metabolites in complex biological matrices, ensuring compliance with strict regulatory standards in drug development and manufacturing.